QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
OTCMKTS:FSNUY

Fresenius SE & Co. KGaA - FSNUY Stock Forecast, Price & News

$6.81
-0.14 (-2.02%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.78
▼
$6.87
50-Day Range
$4.84
▼
$7.10
52-Week Range
$4.79
▼
$10.99
Volume
47,641 shs
Average Volume
173,728 shs
Market Capitalization
$15.33 billion
P/E Ratio
8.30
Dividend Yield
2.31%
Price Target
$39.34

Fresenius SE & Co. KGaA MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
478.1% Upside
$39.34 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.69mentions of Fresenius SE & Co. KGaA in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.25%
From $0.83 to $0.94 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.26 out of 5 stars

See Top Rated MarketRank™ Stocks Here
FSNUY stock logo

About Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Stock

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Stock News Headlines

December 6, 2022 | msn.com
FMC gets new CEO after parent Fresenius flags business review
December 6, 2022 | msn.com
UPDATE 4-FMC boss leaves after two months as Fresenius pushes for changes
December 5, 2022 | bloomberg.com
Fresenius Dialysis Unit CEO to Leave Over Strategic Differences
December 5, 2022 | americanbankingnews.com
Short Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Drops By 8.2%
December 2, 2022 | finance.yahoo.com
Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?
November 30, 2022 | americanbankingnews.com
UBS Group Upgrades Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) to Buy
November 29, 2022 | finance.yahoo.com
Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?
November 27, 2022 | americanbankingnews.com
Bluejay Diagnostics (NASDAQ:BJDX) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Financial Comparison
November 21, 2022 | theglobeandmail.com
$FME : Fresenius Medical Care Enters Monthly Buying Area
November 21, 2022 | uk.finance.yahoo.com
COMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius SE EUR 3.5yr & 7yr
November 21, 2022 | markets.businessinsider.com
EQS-AFR: Fresenius SE & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
November 9, 2022 | finance.yahoo.com
Fresenius SE KGaA Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
November 8, 2022 | markets.businessinsider.com
Fresenius Medical Care North America Named Among 100 Healthiest Workplaces
November 4, 2022 | markets.businessinsider.com
Fresenius Medical Care North America Announces FDA Clearance of New Heat Purification System for Hemodialysis Water with Industry-Leading Efficiency
October 31, 2022 | seekingalpha.com
Fresenius SE & Co. KGaA (FSNUF) Q3 2022 Earnings Call Transcript
October 31, 2022 | msn.com
Fresenius cuts guidance again amid macroeconomic pressures and struggling North American unit
October 31, 2022 | finance.yahoo.com
Fresenius Cuts 2022 Views on Worse Outlook for FMC; 3Q Earnings Fell Sharply
October 25, 2022 | finance.yahoo.com
Fresenius CEO signals realignment, confirms call with Elliott - FAZ newspaper
October 12, 2022 | seekingalpha.com
Fresenius cut to Hold at Jefferies citing staffing issues and inflation
October 10, 2022 | finance.yahoo.com
The deal that showed Musk how hard it would be to exit Twitter bid
October 8, 2022 | markets.businessinsider.com
Fresenius Medical Care Named to Newsweek's 100 Most Loved Workplaces for Second Consecutive Year
October 6, 2022 | benzinga.com
Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient
October 5, 2022 | reuters.com
Fresenius taps pre-dialysis kidney care as drugs promise treatment change
September 6, 2022 | benzinga.com
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
August 26, 2022 | nasdaq.com
Partial sale of Fresenius' Helios could be halted - WirtschaftsWoche
See More Headlines
Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FSNUY Company Calendar

Last Earnings
10/30/2022
Today
12/06/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:FSNUY
CUSIP
N/A
CIK
N/A
Web
www.fresenius.com
Phone
(496) 172-6080
Fax
N/A
Employees
316,078
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$39.34
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
+478.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
10 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.82
Trailing P/E Ratio
8.30
Forward P/E Ratio
8.20
P/E Growth
N/A
Net Income
$2.15 billion
Net Margins
4.17%
Pretax Margin
8.74%
Return on Equity
5.58%
Return on Assets
2.32%

Debt

Debt-to-Equity Ratio
0.58
Current Ratio
1.32
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$44.39 billion
Price / Sales
0.35
Cash Flow
$2.30 per share
Price / Cash Flow
2.96
Book Value
$15.51 per share
Price / Book
0.44

Miscellaneous

Outstanding Shares
2,252,949,000
Free Float
N/A
Market Cap
$15.33 billion
Optionable
Not Optionable
Beta
1.17

Social Links


Key Executives

  • Mr. Michael Sen (Age 54)
    CEO, Pres & Chairman of Management Board - Fresenius Management SE
    Comp: $2.19M
  • Dr. Francesco De Meo (Age 59)
    Member of Management Board - Fresenius Management SE
    Comp: $2.3M
  • Dr. Ernst Wastler (Age 64)
    Member of Management Board - Fresenius Management SE
    Comp: $1.76M
  • Dr. Sebastian Biedenkopf (Age 58)
    Chief Legal Officer, HR, Labor Relations Director, Risk Mgmt & Member of Mgmt. Board
    Comp: $1.48M
  • Ms. Sara Hennicken (Age 42)
    Chief Financial Officer
  • Dr. Carla Kriwet (Age 51)
    Members of Management Board - Fresenius Management SE
  • Mr. Markus Georgi
    Sr. VP of Investor Relations
  • Matthias Link
    Sr. VP Corp. Communications

Key Competitors

View All Competitors













FSNUY Stock - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last twelve months. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" FSNUY shares.
View FSNUY analyst ratings or view top-rated stocks.

What is Fresenius SE & Co. KGaA's stock price forecast for 2023?

10 Wall Street research analysts have issued 1-year price objectives for Fresenius SE & Co. KGaA's shares. Their FSNUY share price forecasts range from $24.00 to $87.00. On average, they anticipate the company's stock price to reach $39.34 in the next year. This suggests a possible upside of 478.1% from the stock's current price.
View analysts price targets for FSNUY or view top-rated stocks among Wall Street analysts.

How have FSNUY shares performed in 2022?

Fresenius SE & Co. KGaA's stock was trading at $9.98 on January 1st, 2022. Since then, FSNUY shares have decreased by 31.8% and is now trading at $6.8050.
View the best growth stocks for 2022 here.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 16,900 shares, a drop of 8.2% from the October 31st total of 18,400 shares. Based on an average trading volume of 184,000 shares, the days-to-cover ratio is currently 0.1 days.
View Fresenius SE & Co. KGaA's Short Interest.

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) posted its earnings results on Sunday, October, 30th. The company reported $0.14 EPS for the quarter. The company had revenue of $10.54 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 4.17% and a trailing twelve-month return on equity of 5.58%.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.31%. The dividend payout ratio is 19.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FSNUY will have a dividend payout ratio of 17.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FSNUY.

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $6.81.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) has a market capitalization of $15.33 billion and generates $44.39 billion in revenue each year. The company earns $2.15 billion in net income (profit) each year or $0.82 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

The company employs 316,078 workers across the globe.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The official website for the company is www.fresenius.com. The company can be reached via phone at (496) 172-6080 or via email at ir-fre@fresenius.com.

This page (OTCMKTS:FSNUY) was last updated on 12/6/2022 by MarketBeat.com Staff